identified neoantigen‐specific lymphocytes in the peripheral blood of melanoma patients and demonstrated that circulating CD8+ PD‐1+ lymphocytes closely resemble the tumor‐resident anti‐tumor lymphocyte population.[130] Similarly, Siddiqui et al. This evidence concerns the gene PDCD1 and melanoma.